CNS Pharmaceuticals's chart data is dated 2026-10-08. There is no active technical signal. There are 7 published signal records.
CNS Pharmaceuticals last closed at $5.35 (-1.47%) on 2026-10-08. Listed on Nasdaq. Trailing 12 months PER is -2.2×. Its overall grade ranks 327 of 738 stocks in Healthcare.
About this company
CNS Pharmaceuticals last closed at $5.35 (-1.47%) on 2026-10-08. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B · 327/738
Valuation grade B+
Related stocks
- Jazz PharmaceuticalsCompetitor
CNS/뇌종양 치료제 개발 분야의 상업화 경쟁사
- Bristol Myers SquibbCompetitor
종양학 대형 제약사로 CNS 암 치료 경쟁 영역에 포함
- NovartisCompetitor
항암·희귀질환 파이프라인을 보유한 글로벌 제약 경쟁사
About CNS Pharmaceuticals
- What technical signals does CNS Pharmaceuticals (CNSP) have?
- CNS Pharmaceuticals current technical signals: no active technical signal.
- Is CNS Pharmaceuticals a cup-and-handle pattern?
- No. CNS Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for CNS Pharmaceuticals?
- Market cap: $3.32M. Trailing 12 months PER: -2.2×. Latest quarter PBR: 2.01×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about CNS Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.